Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Other Non-Current Liabilities (2016 - 2023)

Immucell (ICCC) has disclosed Other Non-Current Liabilities for 8 consecutive years, with $58526.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Other Non-Current Liabilities changed N/A year-over-year to $58526.0, compared with a TTM value of $58526.0 through Dec 2019, changed N/A, and an annual FY2019 reading of $58526.0, changed N/A over the prior year.
  • Other Non-Current Liabilities was $58526.0 for Q4 2019 at Immucell, down from $86973.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $227416.0 in Q2 2016 and bottomed at $996.0 in Q4 2017.
  • Average Other Non-Current Liabilities over 4 years is $81328.4, with a median of $57216.0 recorded in 2019.
  • The sharpest move saw Other Non-Current Liabilities surged 514.54% in 2016, then tumbled 97.33% in 2017.
  • Year by year, Other Non-Current Liabilities stood at $78525.0 in 2015, then plummeted by 52.44% to $37346.0 in 2016, then crashed by 97.33% to $996.0 in 2017, then surged by 5776.1% to $58526.0 in 2019.
  • Business Quant data shows Other Non-Current Liabilities for ICCC at $58526.0 in Q4 2019, $86973.0 in Q3 2019, and $57216.0 in Q2 2019.